Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 6:48 PM
Ignite Modification Date:
2025-12-24 @ 6:48 PM
NCT ID:
NCT02010957
Eligibility Criteria:
Inclusion Criteria
* Patients aged \>= 30 years
* with a solid indeterminate adrenal mass with a diameter \> 3 cm or an increase in tumor diameter of \> 1 cm after the initial evaluation
* with an attenuation value of the adrenal tumor \>= 10 Hounsfield units (HU) in unenhanced computerized tomography (CT)
* scheduled for surgery or biopsy within 3 months
* Written informed consent
* ECOG performance status 0-2
* Effective contraception in female patients of childbearing potential
* Negative pregnancy test in women of childbearing potiential
* Ability to comply with protocol procedures
Exclusion Criteria
* Pregnancy or breast feeding
* Patient unfit or unwilling to undergo surgery / biopsy
* Diagnosis of pheochromocytoma
* Diagnosis of primary hyperaldosteronism
* Diagnosis of Cushing´s syndrome
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
30 Years
Study:
NCT02010957
Study Brief:
Protocol Section:
NCT02010957